The healthcare sector is poised for a surge in IPOs and mergers by 2025, driven by optimism from executives despite geopolitical tensions being cited as the primary risk. Major deals, such as Johnson & Johnson's $13.1 billion acquisition of Shockwave Medical, underscore this growth, with 72% of professionals anticipating increased M&A activity, particularly in Europe. Additionally, nearly two-thirds expect a rise in healthcare IPOs, indicating a revitalized equity capital market.
